The MSCRF Commercialization Program by TEDCO funds Maryland-based projects advancing human stem cell technologies from research toward clinical and commercial application.
The MSCRF Clinical Program by TEDCO funds clinical research using human stem cells to advance new therapies, with all work conducted at Maryland clinical trial sites.
TEDCO’s MSCRF Manufacturing Assistance Program funds Maryland-based research to advance GMP manufacturing of human stem cell therapies and accelerate cell therapy commercialization.
The MSCRF Launch Program by TEDCO funds innovative human stem cell research in Maryland, supporting early-career and transitioning investigators to advance science and collaboration.
The MSCRF Validation Program by TEDCO funds Maryland academic teams to validate and advance human stem cell technologies toward commercial use.
The MSCRF Discovery Program from TEDCO funds innovative human stem cell research in Maryland, supporting novel basic and translational science to advance regenerative medicine.